Development of an equitable, accessible, and cost-effective in-vivo therapy for durable remission of HIV
MarPam Pharma LLC in Landfall Village, Minn. seeks to advance a technology to target and kill HIV-infected T cells, make T cells resistant to HIV infection, and eliminate the virus from patients.